Barron’s on Zoetis

Barron’s mentions some healthcare stocks including Zoetis.

They include the animal-health firm Zoetis (ZTS), down 40% this year, which trades at a 45% discount to its mean target price of $212.80. Zoetis ZTS –1.27% shares climbed sharply throughout the pandemic, jumping more than 80% between the end of 2019 and the end of 2021. This year, the stock has given away a good chunk of those gains.

In a note out early in November, William Blair analyst Brandon Vazquez wrote that the company sees a strong demand for pets, despite the broader economic environment.

“Despite noise in the quarter, management was clear that there has not been a slowdown in companion animal demand, and it expects this segment can remain resilient even in difficult macroeconomic conditions,” Vazquez wrote.

Posted by on November 16th, 2022 at 3:35 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.